Anjali Singh,César Boggiano,Dwight E. Yin,Laura Polakowski,Sai Majji,Wolfgang W. Leitner,Ofer Levy,Kristina De Paris
出处
期刊:Science Translational Medicine [American Association for the Advancement of Science (AAAS)] 日期:2024-09-04卷期号:16 (763)
标识
DOI:10.1126/scitranslmed.abq7378
摘要
Elucidating optimal vaccine adjuvants for harnessing age-specific immune pathways to enhance magnitude, breadth, and durability of immunogenicity remains a key gap area in pediatric vaccine design. A better understanding of age-specific adjuvants will inform precision discovery and development of safe and effective vaccines for protecting children from preventable infectious diseases.